Chieh-Lin Jerry Teng
Overview
Explore the profile of Chieh-Lin Jerry Teng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
329
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Huang Y, Chiu S, Tseng J, Chen J, Wei T, Chu C, et al.
J Cell Physiol
. 2022 Oct;
237(12):4517-4530.
PMID: 36250981
Golgi apparatus (GA) and centrosome reposition toward cell leading end during directional cell migration in a coupling way, thereby determining cell polarity by transporting essential factors to the proximal plasma...
22.
Teng C, Tan T, Pan Y, Lin Y, Lien P, Chou H, et al.
Cancer Control
. 2022 Sep;
29:10732748221124865.
PMID: 36134681
Introduction: While Hodgkin lymphoma (HL) is mostly curable, outcomes for advanced-stage HL remain unsatisfactory. The International Prognostic Score and its modifications were developed to predict HL prognosis; however, more straightforward...
23.
Liao P, Cheng S, Chou C, Lin H, Lin C, Chen T, et al.
Clin Med Insights Oncol
. 2022 Sep;
16:11795549221123617.
PMID: 36134036
Background: Palliative chemotherapy is the preferred standard of care for patients with metastatic gastric cancer (mGC). It remains uncertain whether older patients with mGC would benefit from palliative chemotherapy. This...
24.
Chen H, Shih Y, Wang H, Sun Y, Wang R, Teng C
J Biophotonics
. 2022 Sep;
15(12):e202200143.
PMID: 36053802
It is unclear whether a hyperspectral imaging-based approach can facilitate the diagnosis of diffuse large B-cell lymphoma (DLBCL), and further investigation is required. In this study, the pixel purity index...
25.
Su Y, Kuo M, Chen T, Wang M, Yang Y, Ma M, et al.
Cancer Sci
. 2022 Jul;
113(10):3518-3527.
PMID: 35869805
Several studies have compared the molecular responses between e14a2 and e13a2 BCR::ABL1 transcripts in chronic myeloid leukemia (CML) patients treated with front-line imatinib, but there were very limited studies on...
26.
Wang Y, Teng C, Chai J, Wu C, Chen P, Chen H
Diagnostics (Basel)
. 2022 May;
12(5).
PMID: 35626313
Objectives: Epidural blood patching (EBP) is the mainstay therapy for spontaneous intracranial hypotension (SIH). MRI is used for evaluating spinal CSF leakage. Post-EBP MRI has been. shown to be effective...
27.
Wu C, Gau J, Teng C, Shih Y, Su Y, Wang R, et al.
Diagnostics (Basel)
. 2022 May;
12(5).
PMID: 35626262
Double-hit (DH) genetics induces a reduction in the complete remission (CR) and, consequently, in poor overall survival (OS) in diffuse large B-cell lymphoma (DLBCL) patients. Unfortunately, DH identification is time-consuming....
28.
Chang K, Teng C, Hsu Y, Tsai S, Lin H, Hsieh T, et al.
Toxics
. 2022 Apr;
10(4).
PMID: 35448437
Air pollutants as risk factors for benign brain tumor (BBT) remain unclear. Therefore, we conducted a nationwide retrospective cohort study by integrating the patients' clinical data and daily air quality...
29.
Lin C, Chen T, Shih Y, Chou C, Hsu C, Li P, et al.
J Int Med Res
. 2022 Feb;
50(2):3000605221078466.
PMID: 35187981
Objective: The outcomes of patients with acute myeloid leukemia (AML) who relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) are poor. However, the risk factors for relapse in this context...
30.
Yu T, Yu S, Wang R, Lai S, Teng C, Lin J, et al.
J Formos Med Assoc
. 2022 Jan;
121(7):1215-1222.
PMID: 35022156
Background/purpose: The early progression of disease (POD) of Hodgkin lymphoma (HL) leads to a poor prognosis. To identify risk factors for early POD, this retrospective two-center cohort analysis was conducted....